CHP Seminar: 9th February 2018 – Reducing potentially inappropriate prescribing in primary care in Ireland: An economic evaluation of the OPTI-SCRIPT intervention

12.30pm-1.30pm Friday 9th February
Room 410, Level 4, 207 Bouverie Street, Carlton

Presenter: Paddy Gillespie – Professor of Health Economics at the J.E. Cairnes School of Business & Economics and the Director of the Health Economics & Policy Analysis Centre (HEPAC) at the National University of Ireland, Galway.

Potentially inappropriate prescribing describes sub-optimal prescribing practices that may increase the risk of adverse drug events in circumstances where safer, more effective treatment alternatives are available. In addition to the adverse health implications, potentially inappropriate prescribing may also be associated with increased healthcare utilisation and costs.This study examines the cost effectiveness of an intervention to reduce potentially inappropriate prescribing for older patients in Ireland.

An economic evaluation, employing cost effectiveness analysis and cost utility analysis, was conducted alongside a cluster randomised controlled trial over a 12 month follow up period, to compare the OPTI-SCRIPT intervention to usual practice in Irish primary care. While there was evidence that the OPTI-SCRIPT intervention was effective in reducing potentially inappropriate prescribing in primary care, uncertainty exists with respect to its cost effectiveness. Further studies should explore the health and economic implications of interventions targeting potentially inappropriate prescribing.

For more details, please view the event flyer.

All other enquiries to CHP-enquiries@unimelb.edu.au, Tel: 03 8344 9111.